These findings suggest that TRIM6 may act as a tumor promoter in Gliomas by activating multiple signaling pathways, with the Cytokine-cytokine receptor interaction pathway being one of the most significantly affected pathways. Here, TRIM6 is linked to central nervous system cancer.